NKF 2011 Spring Meeting Coverage


Follow our archived coverage from the National Kidney Foundation's 2011 Spring Clinical Meetings in Las Vegas, including our four sections below that were updated with multiple stories daily.



Correcting Anemia Improves Fatigue in Dialysis Patients

LAS VEGAS—Correction of anemia with erythropoiesis-stimulated agents (ESAs) improves fatigue in dialysis patients compared with no treatment, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.

Novel Tool May Help Dialysis Patients with Phosphorus Control

LAS VEGAS—A novel interactive Web-based phosphorus education tool may help to improve phosphorus control in dialysis patients, according to a report at the National Kidney Foundation's Spring Clinical Meetings.

Oral Iron Found to Be the Optimal First Treatment

LAS VEGAS—Oral iron is the optimal first treatment strategy for most iron-deficient, anemic chronic kidney disease (CKD) patients not yet on dialysis, based on a recent analysis presented at the National Kidney Foundation's Spring Clinical Meetings.

CV Risk Factors Undertreated in High-Risk CKD Patients

LAS VEGAS—Modifiable cardiovascular (CV) risk factors remain undertreated in a very high-risk population of patients with chronic kidney disease (CKD), new findings presented at the National Kidney Foundation's Spring Clinical Meetings suggest.

Drug Shows Promise for Treating Calciphylaxis

LAS VEGAS—Sodium thiosulfate may hold promise as a treatment for calciphylaxis in patients with end-stage renal disease (ESRD), researchers reported here at the National Kidney Foundation's Spring Clinical Meetings.

Obesity, Unhealthy Diets, Smoking Raise CKD Risk

LAS VEGAS—Obesity, current smoking, and diet are modifiable risk factors for developing chronic kidney disease (CKD), according to study findings presented at the National Kidney Foundation's Spring Clinical Meetings.

Antioxidant Nutraceutical May Help Treat Secondary Hyperparathyroidism

LAS VEGAS—A novel multivitamin antioxidant nutraceutical may be useful in the treatment of secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients, according to data reported at the National Kidney Foundation's Spring Clinical Meetings.

Bisphosphonates Lower Death Risk Among Women with CKD

LAS VEGAS—Bisphosphonate treatment in women with non-dialysis dependent chronic kidney disease (NDD-CKD) is associated with a decreased risk of death, but not of cardiovascular events, according to data presented at the National Kidney Foundation's Spring Clinical Meetings.

Larger Doses of Maintenance IV Iron May Cut ESA Requirements

LAS VEGAS—Monthly requirements of erythropoiesis-stimulating agents (ESAs) to maintain target hemoglobin levels may be lower with larger doses of maintenance iron, according to data presented at the National Kidney Foundation's Spring Clinical Meetings.

Hyperphosphatemia and Anemia Risk Factors in Diabetic Nephropathy Patients

LAS VEGAS—Albumunuria, proteinuria, lower estimated glomerular filtration rate (eGFR) in patients with diabetic nephropathy are significantly associated with hyperphosphatemia and anemia, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.

Vitamin D Replacement May Lower CV Event Risk

LAS VEGAS—Treatment of 25-hydroxyvitamin D (25(OH)D) deficiency with ergocalciferol in patients with moderate chronic kidney disease (CKD) is associated with a significant reduction in the risk of cardiovascular (CV) events, new data presented at the National Kidney Foundation's Spring Clinical Meetings suggest.

Switch From Darbepoetin to Epoetin May Be Beneficial

LAS VEGAS—Switching anemic pre-dialysis chronic kidney disease (CKD) from darbepoetin to epoetin is associated with longer dosing intervals and lower drug costs, and hemoglobin levels are maintained in the recommended target range, according to a study presented at the National Kidney Foundation's Spring Clinical Meetings.

Study: Women Are At Higher Risk of RCIN

LAS VEGAS—Women with an estimated glomerular filtration rate (eGFR) of 60 mL/min/1.73 m2 or higher are at higher risk than men for experiencing radiocontrast-induced nephropathy (RCIN) following coronary angiography, investigators reported at the National Kidney Foundation's Spring Clinical Meetings.

Paricalcitol Use Lower Among Non-Diabetics On Statins

LAS VEGAS—Statin use by non-diabetic patients with end-stage renal disease may decrease paricalcitol use, researcher reported at the National Kidney Foundation's Spring Clinical Meetings.

Pulmonary Hypertension After a Lung Transplant Predicts RRT Need

LAS VEGAS—Pulmonary hypertension is a strong predictor of the need for renal replacement therapy (RRT) after lung transplantation, according to new findings presented at the National Kidney Foundation's Spring Clinical Meetings.

Sign Up for Free e-newsletters